113. 筋ジストロフィー Muscular dystrophy Clinical trials / Disease details

臨床試験数 : 622 / 薬物数 : 485 - (DrugBank : 99) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 168

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04386304 (ClinicalTrials.gov)	July 13, 2020	1/5/2020	Safety and Biomarker Response to (+)-Epicatechin in Becker Muscular Dystrophy	A Phase 1, Open-label, Dose Escalation Study to Evaluate the Safety and Preliminary Efficacy of Oral ...	Becker Muscular Dystrophy	Drug: (+)-Epicatechin	Epirium Bio Inc.	NULL	Active, not recruiting	16 Years	59 Years	Male	20	Phase 1	United States
2	NCT02964377 (ClinicalTrials.gov)	November 2016	7/11/2016	Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory Adolescents	A Single Center Dose Ranging Pilot Study of (+)-Epicatechinin Non-ambulatory Adolescents With Duchen ...	Duchenne Muscular Dystrophy	Drug: (+)- Epicatechin	Craig McDonald, MD	Cardero Therapeutics, Inc.	Completed	8 Years	17 Years	Male	15	Phase 1/Phase 2	United States

First Previous1Next Last